OKX joint venture files to launch tokenized stock venue

OKXICE, a joint venture between OKX and NYSE parent ICE, has filed with the SEC to launch a tokenized U.S. stock trading venue offering shares in 63 companies.

OKXICE LLC, a joint venture between cryptocurrency exchange operator OKX and New York Stock Exchange parent Intercontinental Exchange, has notified the U.S. Securities and Exchange Commission that it intends to launch a tokenized securities venue.

A public notice dated Oct. 4 lists 63 proposed stock symbols. The companies include Nvidia, Apple, Microsoft and Tesla, along with crypto-related firms such as Strategy, Coinbase, Circle and BitGo.

The platform would operate 24 hours a day, seven days a week. It would use permissioned Uniswap v4 liquidity pools deployed on XLayer, a blockchain network associated with OKX. Each tokenized stock would be paired with USDC, Global Dollar or Tether’s USDT stablecoin.

Andrew Cuomo, co-chair of OKXICE, described tokenized securities as part of the next stage of the digital asset industry. “The digital asset revolution is already transforming our financial system. Tokenized securities are part of what comes next,” he said.

The venue would operate under an SEC innovation exemption that permits limited trading of tokenized U.S. stocks on eligible blockchain-based platforms. The exemption allows tokenized National Market System stocks to trade through automated market makers and liquidity pools, with access restricted to approved participants.

OKX and Intercontinental Exchange formed the joint venture on a 50-50 basis in June to develop infrastructure for tokenized financial products. The SEC issued the temporary exemption in September.

The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.

Articles by this author